Clinical Trial Update: Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cyclophosphamide with either docetaxel or doxorubicin in women with newly diagnosed, surgically resectable breast cancer. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Taxotere (docetaxel)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN